Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J McCarthy

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Idrugs : the Investigational Drugs Journal|October 31, 2007
Considerations for generic oncology FDG-PET/CT protocol preparation in drug developmentWilliam A Hallett, R Paul Maguire, Timothy J McCarthy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2002
Radiosynthesis, in vitro validation, and in vivo evaluation of 18F-labeled COX-1 and COX-2 inhibitorsTimothy J McCarthy, Ahmed U Sheriff, Matthew J Graneto, et al.
International Journal of Occupational and Environmental Health|June 8, 2018
Estimating infants' and toddlers' inhalation exposure to fragrance ingredients in baby personal care productsJiaqi Zhou, Neena K Tierney, Timothy J McCarthy, et al.
Clinical and Translational Science|November 16, 2022
Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital health technologiesElena S Izmailova, R Paul Maguire, Timothy J McCarthy, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 2, 2015
STatistically Assigned Response Criteria in Solid Tumors (STARCIST)Thomas Bengtsson, Sandra M Sanabria-Bohorquez, Timothy J McCarthy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2006
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033Donna S Dorow, Carleen Cullinane, Nelly Conus, et al.
Molecular Imaging|October 26, 2017
Brain Penetration of the ROS1/ALK Inhibitor Lorlatinib Confirmed by PETT Lee Collier, Kevin P Maresca, Marc D Normandin, et al.
Chemical Communications (Cambridge, England)|December 14, 2012
18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's diseaseElisa Calamai, Sergio Dall'Angelo, David Koss, et al.
EJNMMI Research|June 12, 2012
Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignanciesAndrew M Scott, Paul L Mitchell, Graeme O'Keefe, et al.
Neuroimage|September 28, 2010
Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primatesJean-Dominique Gallezot, David Weinzimmer, Nabeel Nabulsi, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Idrugs : the Investigational Drugs Journal|October 31, 2007
Considerations for generic oncology FDG-PET/CT protocol preparation in drug developmentWilliam A Hallett, R Paul Maguire, Timothy J McCarthy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2002
Radiosynthesis, in vitro validation, and in vivo evaluation of 18F-labeled COX-1 and COX-2 inhibitorsTimothy J McCarthy, Ahmed U Sheriff, Matthew J Graneto, et al.
International Journal of Occupational and Environmental Health|June 8, 2018
Estimating infants' and toddlers' inhalation exposure to fragrance ingredients in baby personal care productsJiaqi Zhou, Neena K Tierney, Timothy J McCarthy, et al.
Clinical and Translational Science|November 16, 2022
Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital health technologiesElena S Izmailova, R Paul Maguire, Timothy J McCarthy, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 2, 2015
STatistically Assigned Response Criteria in Solid Tumors (STARCIST)Thomas Bengtsson, Sandra M Sanabria-Bohorquez, Timothy J McCarthy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2006
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033Donna S Dorow, Carleen Cullinane, Nelly Conus, et al.
Molecular Imaging|October 26, 2017
Brain Penetration of the ROS1/ALK Inhibitor Lorlatinib Confirmed by PETT Lee Collier, Kevin P Maresca, Marc D Normandin, et al.
Chemical Communications (Cambridge, England)|December 14, 2012
18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's diseaseElisa Calamai, Sergio Dall'Angelo, David Koss, et al.
EJNMMI Research|June 12, 2012
Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignanciesAndrew M Scott, Paul L Mitchell, Graeme O'Keefe, et al.
Neuroimage|September 28, 2010
Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primatesJean-Dominique Gallezot, David Weinzimmer, Nabeel Nabulsi, et al.
Pageof 4